Effect of Adjuvant Homeopathy with Usual Care in Management of Thrombocytopenia Due to Dengue: A Comparative Cohort Study
Authors:
- 5 March 2019
- journal article
- research article
- Published by Georg Thieme Verlag KG in Homeopathy
- Vol. 108 (03) , 150-157
Abstract
Background Dengue is an emerging threat to public health. At present, no clear modalities are available for the prevention and management of thrombocytopenia due to dengue. This article reports the clinical outcomes of integrative homeopathic care in a hospital setting during a severe outbreak of dengue in New Delhi, India, during the period September to December 2015. Methods Based on preference, 138 patients received a homeopathic medicine along with usual care (H+UC), and 145 patients received usual care (UC) alone. Assessment of thrombocytopenia (platelet count < 100,000/mm3) was the main outcome measure. Kaplan–Meier analysis enabled comparison of the time taken to reach a platelet count of 100,000/mm3. Results There was a statistically significantly greater rise in platelet count on day 1 of follow-up in the H+UC group compared with UC alone (mean difference = 12,337; 95% confidence interval [CI], 5,421 to 19,252; p = 0.001). This trend persisted until day 5 (mean difference = 14,809; 95% CI, 1,615 to 28,004; p = 0.02). The time taken to reach a platelet count of 100,000/mm3 was nearly 2 days earlier in the H+UC group compared with UC alone (H+UC: 3.44 days ± standard error of the mean [SEM] 0.18; 95% CI, 3.08 to 3.80; UC: 5.28 days ± SEM 0.29; 95% CI, 4.71 to 5.86; p < 0.001). Conclusion These results suggest a positive role of adjuvant homeopathy in thrombocytopenia due to dengue. Randomized controlled trials may be conducted to obtain more insight into the comparative effectiveness of this integrative approach. • One hundred and thirty-eight patients took homeopathy along with usual care (H+UC) and 145 patients were given usual care (UC) alone. • Comparative analysis showed significantly greater rise in platelet count on day 1 of follow-up in the H+UC group compared with UC alone. • The time taken to reach a platelet count of 100,000/mm3 was nearly 2 days earlier in the H+UC group compared with UC alone. • These results suggest a positive role of adjuvant homeopathy in thrombocytopenia due to dengue.Keywords
This publication has 21 references indexed in Scilit:
- Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trialThe Lancet, 2017
- Potential Harm of Prophylactic Platelet Transfusion in Adult Dengue PatientsPLOS Neglected Tropical Diseases, 2016
- Correlation study between platelet count, leukocyte count, nonhemorrhagic complications, and duration of hospital stay in dengue fever with thrombocytopeniaJournal of Family Medicine and Primary Care, 2016
- A prospective observational study of dengue fever with thrombocytopenia with reference to treatmentInternational Journal of Research in Medical Sciences, 2016
- An epidemiological study of dengue in Delhi, IndiaActa Tropica, 2016
- Tackling dengue fever: Current status and challengesVirology Journal, 2015
- Economic and Disease Burden of Dengue Illness in IndiaThe American Journal of Tropical Medicine and Hygiene, 2014
- Prophylactic Platelets in Dengue: Survey Responses Highlight Lack of an Evidence BasePLOS Neglected Tropical Diseases, 2012
- Dengue Hemorrhagic Fever in Trinidad and Tobago: A Case for a Conservative Approach to Platelet TransfusionThe American Journal of Tropical Medicine and Hygiene, 2012
- Transfusion support to Dengue patients in a hospital based blood transfusion service in north IndiaTransfusion and Apheresis Science, 2006